Clinical Impact of Mapping Strategies for Treatment of Ventricular Tachycardias in Patients with Structural Heart Disease

2015 ◽  
Vol 38 (5) ◽  
pp. 630-640 ◽  
Author(s):  
HISAKI MAKIMOTO ◽  
IKUTARO NAKAJIMA ◽  
KOJI MIYAMOTO ◽  
YUKO YAMADA ◽  
HIDEO OKAMURA ◽  
...  
2021 ◽  
Author(s):  
Yasuhito Kotake ◽  
Timothy Campbell ◽  
Richard G. Bennett ◽  
Samual Turnbull ◽  
Kaimin Huang ◽  
...  

Author(s):  
Martin Borggrefe ◽  
Erol Tülümen ◽  
Josep Brugada

Ventricular arrhythmias are abnormal rhythms that originate from below the atrioventricular node. They include premature ventricular complexes, ventricular tachycardias, and ventricular fibrillation. Ventricular arrhythmias may occur in patients with structural heart disease (ischaemic heart disease, cardiomyopathies such as dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, etc.) or in patients with a structurally normal heart (genetic arrhythmia syndromes such as long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, or as idiopathic ventricular tachycardias). Symptoms depend on the frequency, duration, and haemodynamic effects of the arrhythmia. They may be asymptomatic or may cause symptoms, such as palpitations, shortness of breath, chest discomfort, dizziness, or syncope, or may present with cardiac arrest. This chapter is focused on the role of antiarrhythmic drugs in the management of ventricular arrhythmias. The recommendations are based on the current guidelines of the European Society of Cardiology for the management of patients with ventricular arrhythmias.


2011 ◽  
Vol 27 (Supplement) ◽  
pp. OP63_5
Author(s):  
Hisaki Makimoto ◽  
Kazuhiro Satomi ◽  
Ikutaro Nakajima ◽  
Atsushi Doi ◽  
Teruki Yokoyama ◽  
...  

2020 ◽  
Vol 6 (1) ◽  
pp. 56-69 ◽  
Author(s):  
Robert D. Anderson ◽  
Geoffrey Lee ◽  
Ivana Trivic ◽  
Timothy Campbell ◽  
Timmy Pham ◽  
...  

2008 ◽  
Vol 31 (12) ◽  
pp. 1585-1591 ◽  
Author(s):  
KERSTIN BODE ◽  
GERHARD HINDRICKS ◽  
CHRISTOPHER PIORKOWSKI ◽  
PHILIPP SOMMER ◽  
JAN JANOUŠEK ◽  
...  

2003 ◽  
Vol 41 (1) ◽  
pp. 81-92 ◽  
Author(s):  
Angel Arenal ◽  
Esteban Glez-Torrecilla ◽  
Mercedes Ortiz ◽  
Julian Villacastín ◽  
Javier Fdez-Portales ◽  
...  

2018 ◽  
Vol 28 (10) ◽  
pp. 1134-1140 ◽  
Author(s):  
Joseph W. May ◽  
Elizabeth L. Carter ◽  
J. Ryan Hitt ◽  
Thomas R. Burklow

AbstractTraditional ambulatory rhythm monitoring in children can have limitations, including cumbersome leads and limited monitoring duration. The ZioTM patch ambulatory monitor is a small, adhesive, single-channel rhythm monitor that can be worn up to 2 weeks. In this study, we present a retrospective cross-sectional analysis of the ZioTM monitor’s impact in clinical practice. Patients aged 0–18 years were included in the study. A total of 373 studies were reviewed in 332 patients. In all, 28.4% had structural heart disease, and 16.9% had a prior surgical, catheterisation, or electrophysiology procedure. The most common indication for monitoring was tachypalpitations (41%); 93.5% of these patients had their symptoms captured during the study window. The median duration of monitoring was 5 days. Overall, 5.1% of ZioTM monitoring identified arrhythmias requiring new intervention or increased medical management; 4.0% identified arrhythmias requiring increased clinical surveillance. The remainder had either normal-variant rhythm or minor rhythm findings requiring no change in management. For patients with tachypalpitations and no structural heart disease, 13.2% had pathological arrhythmias, but 72.9% had normal-variant rhythm during symptoms, allowing discharge from cardiology care. Notably, for patients with findings requiring intervention or increased surveillance, 56% had findings first identified beyond 24 hours, and only 62% were patient-triggered findings. Seven studies (1.9%) were associated with complications or patient intolerance. The ZioTM is a well-tolerated device that may improve what traditional Holter and event monitoring would detect in paediatric cardiology patients. This study shows a positive clinical impact on the management of patients within a paediatric cardiology practice.


Author(s):  
Yasuhito Kotake ◽  
Timothy Campbell ◽  
Richard G. Bennett ◽  
Samual Turnbull ◽  
Kaimin Huang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document